Medical Equipment

Global Endovascular Stent Grafts Market Set for Strong Expansion Reaching $7.13 Billion by 2030 at 37.5% CAGR

March 12, 2026March 12, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Endovascular Stent Grafts Market At The End Of The 2026–2030 Forecast Period?

The endovascular stent grafts market has seen its size increase significantly in recent years. It is forecast to grow from $1.45 billion in 2025 to $1.99 billion in 2026, achieving a compound annual growth rate (CAGR) of 37.9%. Historically, this expansion has been driven by factors including reliance on conventional open surgical procedures, limited availability of advanced stent graft materials, the growing prevalence of vascular diseases, early adoption of coronary and peripheral grafts, and increasing awareness of aortic aneurysm treatments.

The endovascular stent grafts market size is projected to experience substantial growth over the next few years, reaching $7.13 billion in 2030 with a compound annual growth rate (CAGR) of 37.5%. This projected expansion is primarily driven by technological advancements in endovascular stent grafts, an increase in minimally invasive surgeries, a rise in aortic aneurysm and dissection cases, the growing acceptance of hybrid vascular grafts, and the development of cardiovascular healthcare infrastructure. Significant trends anticipated during the forecast period include a greater adoption of minimally invasive endovascular procedures, an escalating demand for customized stent grafts, innovations in hybrid and biologic graft materials, an increase in thoracic and abdominal aortic repair procedures, and an intensified focus on patient safety and regulatory compliance.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20549&type=smp

What Primary Drivers Are Shaping The Development Of The Endovascular Stent Grafts Market?

The rising occurrence of cardiovascular diseases is projected to stimulate the expansion of the endovascular stent graft market moving forward. Cardiovascular disease, defined as a category of conditions impacting the heart or blood vessels, is seeing increased prevalence due to a combination of lifestyle choices, underlying medical issues, genetic predispositions, and environmental elements. Endovascular stent grafts present a valuable solution for managing cardiovascular diseases, focusing on reducing invasiveness and improving patient results. These grafts serve to reinforce weakened vessel walls, thereby preventing ruptures and mitigating the risk of critical complications. For instance, in October 2025, the Australian Institute Of Health And Welfare, an Australia-based government agency, indicated that in 2023, roughly 57,100 adults aged 25 and above experienced acute coronary events, averaging approximately 156 incidents daily. Therefore, the increase in cardiovascular diseases is a key driver for the growth of the endovascular stent grafts market.

What Segment Types Make Up The Endovascular Stent Grafts Market?

The endovascular stent grafts market covered in this report is segmented –

1) By Product: Hemodialysis Access Grafts, Endovascular Stent Grafts, Coronary Artery By-Pass Grafts, Vascular Grafts For Aorta Disease, Peripheral Vascular Grafts

2) By Raw Material: Synthetic Vascular Grafts, Biological Vascular Grafts, Hybrid Vascular Grafts

3) By Application: Cardiac Aneurysm, Kidney Failure, Vascular Occlusion, Coronary Artery Disease

Subsegments:

1) By Hemodialysis Access Grafts: Arteriovenous (AV) Fistula Grafts, Synthetic Hemodialysis Access Grafts, Bioengineered Hemodialysis Access Grafts, Coated Hemodialysis Grafts, Endovascular Hemodialysis Grafts

2) By Endovascular Stent Grafts: Aneurysm Stent Grafts, Stent Grafts For Aortic Dissection, Thoracic Endovascular Stent Grafts, Abdominal Endovascular Stent Grafts, Biliary Endovascular Stent Grafts

3) By Coronary Artery By-Pass Grafts: Saphenous Vein Grafts (SVG), Arterial Coronary Bypass Grafts, Endovascular Coronary Artery Bypass Grafts (CABG), Synthetic Coronary Bypass Grafts

4) By Vascular Grafts For Aorta Disease: Endovascular Aortic Stent Grafts, Aortic Aneurysm Grafts, Aortic Bypass Grafts, Thoracoabdominal Aortic Stent Grafts, Aortic Dissection Stent Grafts

5) By Peripheral Vascular Grafts: Carotid Artery Stent Grafts, Femoral Artery Stent Grafts, Popliteal Artery Stent Grafts, Iliac Artery Stent Grafts, Peripheral Endovascular Stent Grafts

Which Market Trends Are Creating New Opportunities In The Endovascular Stent Grafts Market?

Companies operating within the endovascular stent grafts market are prioritizing the creation of novel products, such as thoracic aortic stent-grafts, to bolster the precision and effectiveness of treating thoracic aortic aneurysms and dissections. These innovations seek to enhance patient outcomes and resolve intricate anatomical challenges through advanced technology and design enhancements. A thoracic aortic stent graft is a specialized medical instrument utilized in endovascular surgery to address illnesses and conditions of the thoracic aorta—the segment of the aorta situated in the chest—offering a blend of safety, efficacy, and ease for managing thoracic aortic diseases. For instance, in February 2024, Endovastec, a medical device company based in China, unveiled the Multi-Branch Thoracic Aortic Stent-Graft System (Hector) and performed its inaugural clinical application in Switzerland. The Hector system signifies a substantial leap forward in endovascular stent graft technology, with its multi-branch configuration allowing for the treatment of complex thoracic aortic conditions by accommodating and safeguarding essential aortic branches, such as the arteries that supply vital organs.

Who Are The Key Players Driving Competition In The Endovascular Stent Grafts Market?

Major companies operating in the endovascular stent grafts market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Terumo Corporation, Cook Group Incorporated, Merit Medical Systems Inc., Biotronik SE & Co KG, MicroPort Scientific Corporation, Endologix LLC, LeMaitre Vascular Inc., Lifetech Scientific Corporation, W. L. Gore & Associates Inc., Braile Biomedica, BrosMed Medical BV, Micro Interventional Devices Inc. (MID), Lombard Medical Inc., Endovastec Medical Technology Co Ltd., Jotec GmbH, Bentley InnoMed GmbH, Bolton Medical Inc., Alvimedica, Endospan Ltd., Vivasure Medical Ltd.

Read the full endovascular stent grafts market report here:

https://www.thebusinessresearchcompany.com/report/endovascular-stent-grafts-global-market-report

How Does The Endovascular Stent Grafts Market Perform Across Major Global Regions?

North America was the largest region in the endovascular stent grafts market in 2025. The regions covered in the endovascular stent grafts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Endovascular Stent Grafts Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20549&type=smp

Browse Through More Reports Similar to the Global Endovascular Stent Grafts Market 2026, By The Business Research Company

Embolization Coils Market Report 2026

https://www.thebusinessresearchcompany.com/report/embolization-coils-global-market-report

Aortic Aneurysm Market Report 2026

https://www.thebusinessresearchcompany.com/report/aortic-aneurysm-global-market-report

Aortic Aneurysm Market Report 2026

https://www.thebusinessresearchcompany.com/report/aortic-aneurysm-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795